Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma
Masahiro Akimoto(Yokohama City University Medical Center), Hideaki Nakajima(National Institute of Advanced Industrial Science and Technology), Hiroyuki Takahashi(The University of Tokyo), Shin Fujisawa(Yokohama City University Medical Center), Ayako Matsumura(Yokohama City University), Yuto Hibino(Kanagawa Prefectural Hospital Organization), Haruka Teshigawara(Yokohama City University), Hiroyuki Fujita(Kanazawa University), Hiroshi Teranaka(Yokohama City University Medical Center), Katsumichi Fujimaki(Fujisawa City Hospital), Takaaki Takeda(Fujisawa City Hospital), Yuki Nakajima(Fujisawa City Hospital), Takuya Miyazaki(Kanagawa Prefectural Hospital Organization), Rika Sakai(Yokohama City University Medical Center), Takuma Ohashi(National Institute for Environmental Studies), Kenji Matsumoto(Johns Hopkins University), Chizuko Hashimoto(Yamato Municipal Hospital), Mayumi Tokunaga(Kanagawa Prefectural Hospital Organization), Taisei Suzuki(Hiratsuka City Hospital)
Cited by 3
Related Papers
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
|Blood|2008|149
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
|Journal of Clinical Investigation|2005|112
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
|Journal of Clinical Investigation|2005|110